For decades, the Princess Margaret Cancer Centre has been at the forefront of transformative cancer care. Through world-first discoveries, cutting-edge clinical trials, and an enduring commitment to innovation in care, we are redefining every step of the cancer journey from early detection to advanced treatments and long-term survivorship.
This year marked the 40th anniversary of the discovery of the T-cell receptor – a landmark achievement that revolutionized our understanding of the immune system and laid the foundation for modern immunotherapies. In our 2024 Annual Report, we highlight how our scientists and researchers continue to build on that legacy.
Our clinical trials programs continue to shape global standards of care and contribute to new cancer therapies. Our Radiation Medicine Program remains the largest single-site program of its kind in North America, delivering world-class patient care.
We were proud to achieve Exemplary Standing – the highest level of accreditation awarded by Accreditation Canada - with 100% of required organizational practices met. Princess Margaret was also recognized as the top cancer hospital in Canada by Newsweek.
This year we saw the reopening of the Princess Margaret Lodge following years of extensive renovations, once again offering comfortable, affordable accommodation and support for out-of-town patients. To further expand our capacity, we launched the Stem Cell 2 construction project, which will enhance care for patients with complex malignant hematology conditions.
Beyond our walls, we continue to strengthen our Princess Margaret Cancer Care Network and our Global Cancer Program, adding new partners to foster collaborations. We also established a landmark agreement with the University of Waterloo to use artificial intelligence, machine learning, and quantum technology to revolutionize cancer research, care, and education.
Looking to the future, we are preparing for the next era of cancer care with the purchase of 522 University Avenue. The Cancer Futures building will help manage the growing demand for cancer treatment and set new standards of care to improve patient outcomes. As we continue to push the boundaries of what is possible, our legacy inspires us to always move forward.
We extend our sincere thanks to our donors and The Princess Margaret Cancer Foundation for their unwavering support, and to our exceptional staff, nurses, volunteers, and learners – the heart of everything we do.
Keith Stewart,
MB ChB, MBA
Director, Princess Margaret Cancer Centre
Vice President, Cancer,
Laboratory Medicine and Pathology,
University Health Network
